Vanguard Group Inc Vera Therapeutics, Inc. Transaction History
Vanguard Group Inc
- $5.97 Trillion
- Q2 2025
A detailed history of Vanguard Group Inc transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 3,001,108 shares of VERA stock, worth $59.4 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,001,108
Previous 2,918,423
2.83%
Holding current value
$59.4 Million
Previous $70.1 Million
0.86%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding VERA
# of Institutions
198Shares Held
63.7MCall Options Held
723KPut Options Held
193K-
Avoro Capital Advisors LLC New York, NY5.7MShares$113 Million2.22% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.75MShares$94.1 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.34MShares$66.1 Million0.0% of portfolio
-
Abingworth LLP London, X02.96MShares$58.6 Million19.0% of portfolio
-
Sofinnova Investments, Inc. Menlo Park, CA2.79MShares$55.3 Million4.94% of portfolio
About Vera Therapeutics, Inc.
- Ticker VERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,042,300
- Market Cap $535M
- Description
- Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...